This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.
We clinicians, for the most part, continue to treat all nonhemorrhagic shock with pressor agents despite a vague awareness of studies suggesting that this may be of limited value and that other available measures may be more effective. The editor was prompted to the present book because "The critical shock mechanism still remains an elusive entity we are now in... a period of reassessment of the subject to formulate research criteria and to direct attention to facets of the problem... to bring more form and shape to current and future study of the syndrome." Thus, he commissioned 16 essays, each specifically directed toward one organ, system, or topic. About half of the essays present data and develop the argument from tables and charts of the author's own work. Others review the pertinent literature. Most essayists closely adhere to their topics and a terse summary of the present position and gaps
Iber FL. Shock. Arch Intern Med. 1965;115(1):119–120. doi:10.1001/archinte.1965.03860130121046
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: